• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
DSGN

DSGN

Design Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD10.44

+0.27 (+2.65%)

Rating:C+

Company Profile

CEO

Pratik Shah

IPO Date

2021-03-29

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$10.15

Prev. Close

$10.17

Day Low

$10.15

Day High

$10.60

52W Low

$3.33

52W High

$17.25

Market Cap

$0.65B

Volume

0.61M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

6

Avg Positive

15.7%

Avg Negative

2.0%

Avg Neutral

82.3%

News Feed

Design Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

GlobeNewsWire·6/7/2021·↑ positive

Design Therapeutics Expands Board of Directors with Key Appointments

GlobeNewsWire·6/7/2021·↓ negative

Design Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewsWire·3/30/2021·↑ positive

DSGN Stock Price Increased 107.45% In Market Debut: Details

Pulse2·3/26/2021·↑ positive

Design Therapeutics Announces Pricing of Initial Public Offering

GlobeNewsWire·3/25/2021·↑ positive

Design Therapeutics Seeks $228 Million In U.S. IPO

Seeking Alpha·3/24/2021·↑ positive